"My #3 rant is a question about ISRG and "remote" surgery. Isn't that one of the things this is used for? "
No. It's not really used for telesurgery and that's why I was confused. It could be used that way, and they have performed successful remote procedures (i.e., Operation Lindbergh being the first) to demonstrate that capability, but that mode of operation is very rare at this time.
"For instance, a Dr in New York performs a remote robotic surgery on a child in Mumbai?"
Any doctor performing an operation, in this direction, is very likely to be doing it pro-bono (or close to it). The opposite has been brought up before where lower cost surgeons from, say India, perform operations for wealthier countries for lower costs. Kinda like some companies here in the US outsource software development to other Asian countries.
"How does the compensation work?"
Not really sure because it's not very common. Either way, telesurgery still requires an anesthesiologist and a backup surgeon ON location in case there are communications issues or a malfunction in the robot.
ISRG does NOT make any money on the operation itself. ISRG does make considerable money selling the machine, from the disposable attachments used during the operation, and the service contracts for the system.
"I am honest in my opinions and respect the same."
My initial intent was not to necessarily insult you but one does have to leap pretty far to conclude that just because a company grants some of their equipment to teaching facilities is in no way an indication that they are having trouble selling their machines and have to "give them away".
To the contrary, it's very smart given my previous statements about training and to further "lock-in" more surgeons to their technology - which subsequently results in more sales for the company down the road. If those facilities can train hundreds of surgeons and those same surgeons require/demand a da Vinci when they join a hospital - who wins here?
Well, let's just say that these types of technology grants are long overdue in my opinion. ISRG is in no way obligated to train surgeons to use the system, but I do think that they placed too much reliance on the hospitals to perform the necessary training - even though ISRG has hosted a plethora of training sessions in conjunction with choice teaching hospitals. Up to this point, the demand has overpowered the ability to make sure surgeons migrating from lap and open surgery are properly trained. This lack of training (teaching old dogs new tricks) is the ONLY thing that has held ISRG back to any degree and has provided fodder for critics to question the system. Most of the underlying critics are the older surgeons that have refused to migrate but feel threatened by the newer technology and the younger generation that are proficient with the robotic systems.
But let me say this because I'm a software engineer. When I first started my career it was a time when COBOL developers were in high demand. I had to take COBOL classes in college and I almost dropped out because I hated the environment it represented. However, I persevered, graduated and found that I loved developing PC/Web type applications. Over the course of my career, and like most in my field, we sought out and migrated towards tools that provide the best ability to deliver quality systems to our customers. For each and every tool migration that I tackled, never did I look back and wish to return to the older tool set. In the same manner, once these surgeons are adequately trained, they will NEVER want to return to the outdated modes of operating procedures - it's that simple. ISRG is THE "Microsoft" of this generation of surgeons and the COBOL surgeons are withering away.
That explanation covers your #1 and #2. In regards to your #3 rant, I have no idea what question you are really trying to ask.
"There is nothing about this news that is bad for the shorts other than that the longs are bidding the stock up like crazy"
It's my opinion that Intuitive ought to just outright buy them rather than negotiate a new deal. One of the main unwarranted criticisms of ISRG is that their technology increases the cost of procedures. Having Novadaq's technology as part of their portfolio of products - which already wonderfully complements their own - may tend to soften some of that criticism.
"There use to be an IDIOT named SAMPLEPLAN..."
Ahhhh, yes he and INDY hooking up...thanks for the memory.
Sorry for your situation...
If I had it my way I would outlaw short selling. There is no reason for it and I never understood the purpose for allowing it. The market was created to help companies grow - not to bet on their demise. Now, the Citron's of the world are turning it into a casino...a casino were they themselves cannot be prosecuted for misleading and cheating...
Egad is right!! It's just not your lucky week is it Fido? You shorted Zillow as well didn't you?
"..and let us long-suffering Shorts have our turn at profits. Z doesn't report eps until Aug. 4th...by then, much of your long gains will be gone unless you just be reasonable and cooperated NOW."
You've stopped by this MB off and on for some time. How would you not know that the Japan market (and thus selling) has been opened for quite some time?
With this news, the status quo has not really changed - it's simply a transition away from their Japanese selling partner/distributor to ISRG which will now directly perform these services themselves.
"Intuitive Surgical and Adachi will work together to ensure da Vinci customers in Japan experience a smooth transition. In addition, Intuitive Surgical will offer employment to a number of Adachi employees who have experience with the da Vinci business. These employees will be added to Intuitive Surgical's existing regulatory team, call center and other departments to further strengthen the highly capable organization."
It seems that Yahoo has temporarily banned you for posting too much logic. In order to release the ban, you must spend some time going to other various message boards claiming that you made big bucks using "underground stock alerts".
PS: It helps if you have lots of friends that immediately thank you for that wonderful information...
" It is my opinion that ISRG does not want to branch into a new field, but would rather ..."
This has been ISRG's one management blunder in my opinion. They NEED to use some of that cash to acquire proven companies (like NVDQ) that tie directly to their product line. In other words, they need to have other related business entities that can produce positive growth and positive news to offset the periodic uncertainties that surround their sole product - da Vince.
Early on, Intuitive saw NVDQ's opportunities and value. Why they didn't acquire them when the stock was in the $4 range is beyond me. However, if I'm not mistaken, I thought ISRG was a major stockholder of NVDQ?
#1 there was no hint that this was coming.
Any hospital that has been using the da Vinci for any length of time should have known themselves that ISRG was due to release a new version at any time. This argument could have been used for any subsequent version that they ever introduced.
In regards to the compatibility issues, I agree that is somewhat of a pain for those hospitals but I also think it points to a radical and possibly revolutionary design version of the robot. Sometimes, you just have to bite the bullet and make these hard decisions in order to create this type of leap in technology.
If ISRG feels that these "issues" really are issues then I'm fairly confident that ISRG will try and minimize the effects on their customers - either through very good deals on upgrade trade-ins and/or finding new markets for older systems to be sold.